Drugs Made In America Acquisition Corp. Units (DMAAU) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Drugs Made In America Acquisition Corp. Units (DMAAU) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($137.91K) in capital expenditures ($4.00). See Drugs Made In America Acquisition Corp. (DMAAU) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$137.91K
USD
Capital Expenditures
$4.00
USD
Data as of
Sep 2025
Most recent filing
Annual Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Units (None–None)
Year-by-year Capital Reinvestment Ratio for Drugs Made In America Acquisition Corp. Units from None to None. For live market cap and broader valuation context, see Drugs Made In America Acquisition Corp. (DMAAU) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow